ML Strategies
Viewpoints
Filter by:
Industrial Decarbonization Gets Boost in Latest DOE Funding Opportunity
March 14, 2024 | Alert | By John Lushetsky, R. Neal Martin, Myria S. Garcia
DOJ Deputy Chief Announces “Stiffer Sentences” for AI-Related White-Collar Crime — AI: The Washington Report
March 14, 2024 | Article | By Bruce Sokler, Alexander Hecht, Christian Tamotsu Fjeld, Raj Gambhir
DOJ and FTC Weigh in on Alleged Algorithmic Price Fixing — AI: The Washington Report
March 7, 2024 | Article | By Bruce Sokler, Alexander Hecht, Christian Tamotsu Fjeld, Raj Gambhir
FTC Hosts Panel and Launches Public Inquiry with DOJ and HHS on Private Equity and Health Care
March 6, 2024 | Advisory | By Karen Lovitch , Bruce Sokler, Joseph Miller , Raj Gambhir
Proposed FTC Rule Would Hold AI Companies Liable for “Deepfake” Impersonation Scams — AI: The Washington Report
February 29, 2024 | Advisory | By Bruce Sokler, Christian Tamotsu Fjeld, Alexander Hecht, Raj Gambhir
A $1 Billion, 10-year Climate Tech Investment Effort to Come in Massachusetts
February 29, 2024 | Alert | By Steven Baddour, Daniel Connelly, Taylor Shepherd
Energy & Sustainability Connections Newsletter — March 2024
February 27, 2024 | Article | By Thomas R. Burton, III, Sahir Surmeli, Kaoru C. Suzuki
Energy & Sustainability Event Highlights — March 2024
February 27, 2024 | Article | By Thomas R. Burton, III, Sahir Surmeli
Federal and State Lawmakers Launch AI Task Forces — AI: The Washington Report
February 22, 2024 | Article | By Daniel Connelly, Alexander Hecht, Christian Tamotsu Fjeld, Bruce Sokler, Raj Gambhir
Read about AI-focused task forces formed in the House of Representatives and by the governor of Massachusetts in the latest edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI.
Read more
Commerce Department Launches Cross-Sector Consortium on AI Safety — AI: The Washington Report
February 16, 2024 | Article | By Bruce Sokler, Alexander Hecht, Christian Tamotsu Fjeld, Raj Gambhir
Senators Propose Clarification of Antitrust Law to Expressly Cover Algorithmic Collusion — AI: The Washington Report
February 8, 2024 | Article | By Bruce Sokler, Alexander Hecht, Christian Tamotsu Fjeld, Raj Gambhir
Biden’s AI Executive Order Achieves First Major Milestones (AI EO January Update) — AI: The Washington Report
February 2, 2024 | Article | By Bruce Sokler, Alexander Hecht, Christian Tamotsu Fjeld, Raj Gambhir
Algorithmic Disgorgement: An Increasingly Important Part of the FTC’s Remedial Arsenal — AI: The Washington Report
January 24, 2024 | Article | By Bruce Sokler, Alexander Hecht, Christian Tamotsu Fjeld, Raj Gambhir
FTC Warns AI Companies to Honor Privacy and Confidentiality Commitments — AI: The Washington Report
January 19, 2024 | Blog | By Michael Katz, Bruce Sokler, Alexander Hecht, Christian Tamotsu Fjeld, Raj Gambhir
(Un)fair Use? Copyrighted Works as AI Training Data — AI: The Washington Report
January 10, 2024 | Article | By Bruce Sokler, Alexander Hecht, Christian Tamotsu Fjeld, Raj Gambhir
AI Judges? Chief Justice Roberts Thinks Not — AI: The Washington Report
January 3, 2024 | Article | By Bruce Sokler, Alexander Hecht, Christian Tamotsu Fjeld, Raj Gambhir
Three Trends in AI Regulation in 2023 — AI: The Washington Report
December 27, 2023 | Article | By Bruce Sokler, Alexander Hecht, Christian Tamotsu Fjeld, Raj Gambhir
2023: Another Year Chock Full of Challenges for FDA
December 20, 2023 | Blog | By Joanne Hawana , Benjamin Zegarelli
In 2023, the FDA navigated challenges while achieving significant public health milestones. Member Joanne Hawana and Of Counsel Benjamin Zegarelli highlight key takeaways from the year, addressing multifaceted issues such as CBD regulation, the overhaul of in vitro clinical tests, and the management of manufacturing failures. These pivotal topics underscore the FDA’s proactive approach to evolving healthcare regulations and technological advancements.
Read more
Explore Other Viewpoints:
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment, Labor & Benefits
- Energy & Sustainability
- Environmental Enforcement Defense
- Environmental Law
- FDA Regulatory
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology